Companies / BOC Sciences / Cibisatamab
BOC Sciences

Cibisatamab | BOC Sciences

Cibisatamab is an anti-carcinoembryonic antigen (CEA) and anti-CD3 bispecific monoclonal antibody used for cancer therapy. Cibisatamab binds to both T cells and CEA-expressing tumor cells, which cross-links the T cells with the tumor cells.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.